As the pharmaceutical industry continues to broaden its global reach and clinical trials increase in size and complexity, it’s clear that more sources than ever before are contributing to the average clinical trial budget. As a result, sponsors’ need for more accurate trial budgets as they plan and secure funding for future research and development has increased. In return, CROs must also effectively manage the funds required from the sponsor to ensure timely funding to sites, which can impact site satisfaction and performance.
Download our white paper to learn about:
- The typical variance — from forecasted to actual costs — for clinical studies
- Specific concerns and challenges for sponsors and CROs
- Current methods and why they are inefficient and inaccurate
- How purpose-built, activity-based automated technology can make budget management and forecasting more efficient and accurate